


The Journal of Diabetes, Metabolism and Endocrinology is committed to transparency and impartiality in scholarly publishing. The journal follows relevant guidance from the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE) concerning the identification, disclosure, and management of conflicts of interest.
A conflict of interest does not necessarily indicate misconduct. However, undisclosed conflicts may undermine confidence in the research, peer-review process, or editorial decision-making. Therefore, all relevant conflicts must be disclosed and appropriately managed.
A conflict of interest (COI) exists when an individual's personal, professional, financial, or other relationships or interests could influence, or could reasonably be perceived to influence, their objectivity or judgment.
Conflicts may be:
Both actual and reasonably perceived conflicts should be considered.
Authors must disclose relevant financial relationships that could influence the research or its interpretation.
These may include:
The disclosure requirement applies regardless of whether the author believes the relationship influenced the research.
Conflicts may also arise from non-financial relationships or interests, including:
Authors should disclose relevant non-financial interests where they could reasonably be perceived as influencing the work.
All authors are responsible for identifying and disclosing relevant conflicts of interest.
A Conflict of Interest Statement should be included in every manuscript, even when no conflicts exist.
Where no relevant conflict exists, authors may use a statement such as:
“The authors declare that they have no conflicts of interest.”
Where conflicts exist, authors should clearly describe the nature of the relationship or interest.
Financial support for the research must be disclosed separately from conflicts of interest where appropriate.
Authors should identify:
If the funder had no role in the research or publication process, this should be stated where appropriate.
The corresponding author should coordinate conflict-of-interest disclosures from all authors and ensure that the information submitted to the journal is complete and accurate.
The corresponding author should not assume that the absence of a disclosure from a co-author means that no conflict exists. Each author remains individually responsible for their own disclosure.
Editors must disclose relevant conflicts of interest and should not handle manuscripts where their impartiality could reasonably be questioned.
An editor should normally recuse themselves when:
Where necessary, the manuscript should be transferred to an independent editor.
Reviewers must disclose any actual, potential, or perceived conflict of interest before accepting a review assignment.
Reviewers should decline to review when they:
Reviewers must not use confidential information obtained during peer review for personal or professional advantage.
Editorial Board membership does not exempt an individual from the journal's conflict-of-interest requirements.
Editorial Board members must disclose relevant interests and must not receive preferential treatment for manuscripts submitted by themselves, their colleagues, institutions, or collaborators.
Manuscripts involving an Editorial Board member should be handled independently where appropriate.
Conflicts may arise when an author's institution, employer, sponsor, or affiliated organization has a financial, regulatory, or professional interest in the research.
Such relationships should be disclosed where they could reasonably influence the research or its interpretation.
Institutional affiliation alone does not constitute a conflict of interest.
Disclosure is the first step; where necessary, the journal may implement additional measures to manage a conflict.
Possible measures include:
The existence of a conflict does not automatically prevent publication. The key consideration is whether the conflict can be appropriately disclosed and managed.
If a relevant conflict is discovered after submission or publication, the journal may investigate the matter.
Depending on the circumstances, the journal may:
Providing deliberately false, incomplete, or misleading conflict-of-interest information may constitute a publication-ethics violation.
The journal reserves the right to take appropriate editorial action where inaccurate disclosure is identified.
Conflicts of interest must be managed without unnecessarily compromising the confidentiality of the peer-review process.
Reviewers must not disclose manuscript content, author information, or editorial correspondence to unauthorized individuals.
Commercial relationships must not influence:
Payment of an Article Processing Charge (APC) does not influence editorial decisions or guarantee publication.
If a significant conflict of interest is identified after publication, the journal will assess whether the published record requires correction or clarification.
Where appropriate, a transparent disclosure may be added to the article so that readers can properly evaluate the research.
The journal follows relevant COPE principles and guidance for identifying and managing conflicts involving authors, reviewers, editors, and publishers.
The journal also follows applicable ICMJE Recommendations concerning disclosure of financial and non-financial relationships and activities that could influence, or appear to influence, scholarly work and editorial decisions.
By submitting a manuscript to the Journal of Diabetes, Metabolism and Endocrinology, authors confirm that:
The journal's objective is not to eliminate every potential conflict but to ensure that relevant conflicts are transparently disclosed, appropriately managed, and prevented from compromising the integrity of the scientific and editorial process.


